Asset comparator
Compare stocks, ETFs, indices, commodities, cryptocurrencies and bonds over the same period. Indicators that are not meaningful for a given asset type are flagged.
- Johnson & Johnson
- Sanofi
Rentabilidad comparada (base 100)
Cada activo vale 100 el 13 de octubre de 2025; un valor de 120 significa +20 % desde esa fecha (última fecha común: 9 de octubre de 2026).
Each performance is calculated in the asset's trading currency, without currency conversion.
Indicadores
«N/A» indica un indicador que no tiene sentido para este tipo de activo: no debe compararse.
| Indicador | Johnson & JohnsonStock | SanofiStock |
|---|---|---|
| Rentabilidad y riesgo | ||
| Performance over the periodChange in price between the first and last common dates. | +37.0% | −15.0% |
| Annualized performanceAverage annual return that would produce the same total performance. | +37.5% | −15.2% |
| Annualized volatilityTypical range of price movements: the higher it is, the more the price fluctuates. | 19.6% | 23.0% |
| Maximum DrawdownLargest decline from peak to subsequent trough over the period. | −11.0% | −22.6% |
| Sharpe RatioReturn achieved above the risk-free rate (5.24%), per unit of volatility. The higher it is, the better risk was rewarded over the period. | 1.81 | -0.80 |
| 1-day 95% Value at RiskOne-day loss that was exceeded in only 5% of cases (historical VaR). | −2.1% | −2.4% |
| Fundamentales | ||
| Market capitalizationTotal market value of all shares (or circulating tokens for a crypto). | 630.04B $ | 85.69B € |
| P/E (trailing 12 months)Share price divided by earnings per share: number of years of earnings paid. | 30.3 | 22.0 |
| Price-to-SalesMarket capitalization divided by annual revenue. | 6.4 | 1.8 |
| Net marginShare of revenue retained as profit. | 21.5% | 8.1% |
| Return on equityReturn on equity (ROE). | 25.7% | 5.7% |
| Revenue growthOver one year, latest published quarter compared with the same quarter of the previous year. | +6.6% | +14.6% |
| Dividend yieldAnnual dividend relative to the share price. | 2.09% | 5.81% |
| Debt / equityFinancial debt relative to shareholders' equity. | 58% | 34% |
Correlaciones en el periodo
De −1 a 1: cerca de 1, los dos activos suben y bajan juntos; cerca de 0, evolucionan de forma independiente.
- Johnson & Johnson / Sanofi0,36
Análisis comparativo
Análisis generado por IALa IA compara los activos seleccionados solo a partir de las cifras anteriores, señalando lo que no es comparable. El texto solo se genera a petición suya.
Información facilitada con fines pedagógicos. No constituye asesoramiento en inversiones ni una recomendación personalizada. Las rentabilidades pasadas no garantizan las rentabilidades futuras.